Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Maine Law Restricts Facial Recognition

Maine passed laws that put a rein on certain facial recognition…
Read more

China’s Nuclear Expansion

A warning from U.S. Navy Adm. Charles Richard, the commander…
Read more

Someone You Know Becoming an Extremist?

Facebook has begun testing a feature that asks their users…
Read more